Unlock instant, AI-driven research and patent intelligence for your innovation.

Intermediates for the preparation of ticagrelor and preparation methods thereof

A technology for controlling temperature and white solids, applied in the field of medicine, can solve the problems of high cost, difficult to control cost, risk of sodium hydride explosion, etc., and achieve the effects of mild reaction conditions, reduction of synthetic routes, and short and novel routes.

Active Publication Date: 2021-03-02
CHANGZHOU PHARMA FACTORY
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] This route uses CBS catalyst, the cost is high, and the smell of dimethyl sulfide is unpleasant, it has great environmental pollution, and the consumption is large, the price is high, and the cost is difficult to control; the sodium hydride used has the risk of explosion, which is a safety hazard in industrial production very big

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Intermediates for the preparation of ticagrelor and preparation methods thereof
  • Intermediates for the preparation of ticagrelor and preparation methods thereof
  • Intermediates for the preparation of ticagrelor and preparation methods thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0034] The preparation method of some intermediates according to claim 1 of the present invention is characterized in that it comprises: subjecting 3,4-difluorostyrene to an addition and cyclization reaction to obtain compound (II); compound (II ) synthetic reaction scheme is as follows:

[0035]

[0036] Among them, compound (I) can be prepared from cheap and easy-to-obtain o-difluorobenzene through Friedel-Crafts, reduction, and dehydration at high yields, and can also be purchased directly.

[0037] According to some embodiments, the cycloaddition reaction of 3,4-difluorostyrene to obtain compound (II) specifically includes: after reacting dimethylacetamide (DMA) and trifluoromethanesulfonic anhydride in the first solvent , and then carry out cycloaddition reaction with 3,4-difluorostyrene and organic base. Dimethylacetamide is first sulfonated under the action of trifluoromethanesulfonic anhydride, and then undergoes cycloaddition with 3,4-difluorostyrene, that is, com...

Embodiment 1

[0073]Dissolve 1.05g of DMA in 14mL of chloroform, lower the temperature to 5°C, add dropwise 3.95g of trifluoromethanesulfonic anhydride, and control the temperature at 5°C, a large amount of white solids precipitate out. solution. 1.4 g of compound (I) and 1.69 g of 2,4,6-collidine were dissolved in 2 mL of chloroform. This solution was added dropwise to the first solution, refluxed for 18h, then 5mL of water was added, and refluxed for 18h. The solution after the reaction was lowered to room temperature, separated into layers, the aqueous layer was extracted with 5 mL of chloroform, the organic layers were combined, the combined organic layers were dried with anhydrous sodium sulfate, and column chromatography was carried out to obtain 1.45 g of a light yellow liquid that is the compound (II), yield 80%.

Embodiment 2

[0075] 2g of compound (II) was dissolved in 20mL of tetrahydrofuran, cooled to -78°C, 12mL of LiHMDS (1M inTHF) was added dropwise, and the temperature was controlled at -60°C. After dropping, keep warm at -60°C for 20 minutes. Then add NBS, raise the temperature to 0°C and keep it warm for 20min. Dissolve 1.1 g of sodium hydroxide in 10 mL of water, add it to the solution after adding NBS and stir overnight at room temperature. Then, the mixed product after stirring and reacting was separated into layers, and the pH of the aqueous layer was adjusted to 4 with 1M dilute hydrochloric acid. The aqueous layer was extracted with 10 mL*2 ethyl acetate, the organic layers were combined, and the organic layer was dried with anhydrous sodium sulfate. Finally, 1.65 g of off-white solid, namely compound (III), was obtained by column chromatography with a yield of 76%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an intermediate for the preparation of ticagrelor, the chemical structure of which is shown in formula (II): the preparation method comprises: subjecting 3,4-difluorostyrene to an addition and cyclization reaction to obtain the compound ( II); the present invention also discloses a method for preparing the compound shown in the chemical structural formula (III), which includes: performing a rearrangement reaction on the compound (II) to obtain the compound (III), the chemical structural formula (III) is: The invention also discloses a preparation method of the compound shown in the chemical structural formula (IV), in which the compound (IV) is obtained after rearranging and splitting the compound (III), wherein the chemical structural formula (IV) is: through the compound (II ) as a key intermediate can greatly shorten the synthetic route of ticagrelor, and further synthesize compound (Ⅲ) and compound (Ⅳ). The synthetic route is short and novel, the reaction conditions are mild, and the yield is high. for large-scale industrial production.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to an intermediate used for preparing ticagrelor and a preparation method thereof. Background technique [0002] Ticagrelor, developed by AstraZeneca, was approved by the FDA on July 20, 2011 to reduce the occurrence of thrombotic events in patients with acute coronary syndrome (ACS). It is a novel, selective anticoagulant drug and the first reversible binding P2Y12 adenosine diphosphate receptor (ADP) antagonist that can reversibly act on vascular smooth muscle cells (VSMC) Purine 2 receptor subtype P2Y12 has obvious inhibitory effect on ADP-induced platelet aggregation, and can effectively improve the symptoms of patients with acute coronary heart disease. In 2012, the trade name of ticagrelor (or ticagrelor), Bilinda, has obtained the import drug license issued by the State Food and Drug Administration (SFDA), which means that this medicine for acute coronary syndrome (ACS) ) ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C49/697C07C45/00C07C51/31C07C61/40C07C209/62C07C211/40C07C59/50C07C51/41C07D487/04
CPCC07C45/00C07C49/697C07C51/31C07C51/412C07C59/50C07C61/40C07C209/62C07C211/40C07D487/04C07C2601/04
Inventor 孙光祥张云然王兵孙海江俞风山朱宏伟
Owner CHANGZHOU PHARMA FACTORY